NSETrading Window24 Jun 2026 · 24 Jun 2026, 05:46 pm

Trading Window

ORTIN GLOBAL LIMITED · ORTINGLOBE

✦ AI Summary

ORTIN GLOBAL LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from 01.07.2026 till 48 hours after the declaration of Unaudited Financial Results for the Quarter ending 30.06.2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

ORTIN GLOBAL LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

ORTINLAB_24062026174618_Closure_of_Trading_Window_SD.pdf

pdf

Download →
View document text
ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 To, Date: 24.06.2026 The Manager The Manager BSE Limited NSE Limited, P.J. Towers, Dalal Street Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400001 Mumbai 400051 (BSE Scrip Code: 539287) (NSE Symbol: ORTINGLOBE) Dear Sir/Madam, Sub: Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 Unit: Ortin Global Limited (formerly known as Ortin Laboratories Limited) With reference to the subject cited and pursuant to the Company’s Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company will remain closed from 01.07.2026 till 48 hours after the declaration of Unaudited Financial Results for the Quarter ending 30.06.2026 for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The Board Meeting will be scheduled, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ending June 30, 2026. Accordingly, an intimation regarding the notice of Board Meeting shall be sent separately to the Stock Exchange. Further, the designated persons have been intimated not to trade in the securities of the Company during the above said period of closure of trading window. This is for the information and records of the Exchange, please. Thanking you. Yours sincerely, For Ortin Global Limited (formerly known as Ortin Laboratories Limited) S. Murali Krishna Murthy Managing Director DIN: 00540632 Regd. Office: D. No. l-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118